Director/PDMR Shareholding

RNS Number : 3924B
Dechra Pharmaceuticals PLC
03 March 2014
 





 

 

 

3 March 2014

 

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

 

Director / PDMR shareholding

 

 

 

Exercise of LTIP options:

 

Dechra Pharmaceuticals PLC announces that on 28 February 2014, the following Director and PDMR exercised options over ordinary shares of 1p each in the Company. The options were granted to them on 22 December 2010 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP): 

 

Name

Capacity

Options Exercised

Shares Sold

Sale Price

per share

 

Total beneficial shareholding following this announcement

Percentage of issued share capital

Ian Page

Director

78,656

37,080

£6.9129

906,643

1.035

Zoe Goulding

PDMR

8,989

4,238

£6.9129

11,933

0.014

 

The exercise of the LTIP options were subject to the achievement of performance conditions which vested at 100% of the total award.

 

Both Ian Page and Zoe Goulding have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.  

 

 

For further information, please contact:

 

Melanie Hall, Assistant Company Secretary             

Telephone number: 01606 814730

 

 

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQKNDNPBKDBNK
UK 100

Latest directors dealings